This post may contain affiliate links.
With summertime in full swing I am enjoying fun in the sun, pool parties, vacation, and outdoor activities with my family. Wearing makeup has taken a backseat to playing, splashing, getting sweaty, and doing everything else that I’m supposed to be doing during the glorious lazy days of summer. As I’ve grown, my beauty routine has evolved from piling on makeup to mask what I considered to be imperfections to doing my best to take care of and nourish my skin so that makeup is optional. I can honestly say that I feel better than ever in the skin that I’m in at 31 than I ever have in my life. But that is not always the case for all women because about 16 million of us (in America) will be starting to experience an inflammatory skin condition called Rosacea that is marked by persistent facial redness. If you’ve been covering up your facial redness instead of treating it, you are not alone. Over 4 in 5 (82%) rosacea sufferers have used cosmetics to cover up redness. Mirvaso® (brimonidine) Topical Gel, 0.33%* is the first and only gel specifically developed and proven to reduce the persistent facial redness of rosacea.
Important Safety Information
- Indication: Mirvaso® (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. Adverse Events: In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin burning sensation and contact dermatitis. Warnings/Precautions: Mirvaso Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud’s phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. Mirvaso Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of Mirvaso Gel by children have been reported. Keep Mirvaso Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
I was selected for this opportunity as a member of Clever Girls Collective and the content and opinions expressed here are all my own.